Igor Sherman

Company: Alpha Cancer Technologies

Job title: CEO and Founder

Seminars:

Exploring Novel Recombinant Human Alpha- Fetoprotein Conjugate for Effective & Safe Targeting of Cancers & Myeloid-Derived Suppressor Cells 2:30 pm

Delving into the use of novel, highly effective and safe protein-drug conjugates Describing how the AFP receptor is a unique target present exclusively on cancer and MDSC cells Highlighting how natural human proteins have been shownto be exceptionally safe in clinical trials and can be used to target AFP receptorsRead more

day: Conference Day One - Track 1 - PM